Sphera Funds Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-20,623
| Closed | -$299K | – | 108 |
|
|
2020
Q1 | $299K | Sell |
20,623
-40,571
| -66% | -$588K | 0.04% | 70 |
|
|
2019
Q4 | $723K | Hold |
61,194
| – | – | 0.06% | 77 |
|
|
2019
Q3 | $1.54M | Buy |
+61,194
| New | +$1.54M | 0.24% | 66 |
|
|
2017
Q4 | – | Sell |
-3,193
| Closed | -$217K | – | 147 |
|
|
2017
Q3 | $217K | Sell |
3,193
-2,327
| -42% | -$158K | 0.03% | 112 |
|
|
2017
Q2 | $522K | Buy |
5,520
+1,949
| +55% | +$184K | 0.09% | 101 |
|
|
2017
Q1 | $513K | Hold |
3,571
| – | – | 0.1% | 93 |
|
|
2016
Q4 | $453K | Buy |
+3,571
| New | +$453K | 0.11% | 88 |
|
|
2015
Q3 | – | Sell |
-5,881
| Closed | -$3.72M | – | 135 |
|
|
2015
Q2 | $3.72M | Sell |
5,881
-309
| -5% | -$195K | 0.36% | 59 |
|
|
2015
Q1 | $3.19M | Buy |
+6,190
| New | +$3.19M | 0.33% | 68 |
|